Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMYT

Amryt Pharma (AMYT) Stock Price, News & Analysis

Amryt Pharma logo

About Amryt Pharma Stock (NASDAQ:AMYT)

Key Stats

Today's Range
$14.63
$14.76
50-Day Range
$14.55
$14.70
52-Week Range
$6.41
$14.77
Volume
2.39 million shs
Average Volume
757,360 shs
Market Capitalization
$940.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMYT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMYT Stock News Headlines

Alembic Pharmaceuticals Ltd.
AMYT Historical Data
Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
Amryt Pharma Stock (NASDAQ:AMYT), Dividends
See More Headlines

AMYT Stock Analysis - Frequently Asked Questions

Amryt Pharma plc (NASDAQ:AMYT) issued its quarterly earnings data on Thursday, November, 5th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.73) by $0.66. The business earned $49.33 million during the quarter. Amryt Pharma had a positive trailing twelve-month return on equity of 1.70% and a negative net margin of 8.19%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amryt Pharma investors own include Alibaba Group (BABA), Dynavax Technologies (DVAX), Advanced Micro Devices (AMD), Teladoc Health (TDOC), NIO (NIO), Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2020
Today
10/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AMYT
CIK
1783010
Fax
N/A
Employees
2,020
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1 million
Net Margins
-8.19%
Pretax Margin
-0.56%
Return on Equity
1.70%
Return on Assets
0.75%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.57
Quick Ratio
0.94

Sales & Book Value

Annual Sales
$222.54 million
Price / Sales
4.22
Cash Flow
$0.98 per share
Price / Cash Flow
14.98
Book Value
$5.58 per share
Price / Book
2.63

Miscellaneous

Outstanding Shares
63,960,000
Free Float
60,343,000
Market Cap
$940.21 million
Optionable
Not Optionable
Beta
0.84

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:AMYT) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners